EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

被引：9
|
作者：
Yazici, Y. [1 ]
McAlindon, T. E. [2 ]
Gibofsky, A. [3 ,4 ]
Lane, N. E. [5 ]
Latterman, C. [6 ]
Skrepnik, N. [7 ]
Swearingen, C. J. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. R. [1 ]
Hochberg, M. C. [8 ]
机构：
[1] Samumed, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Med Ctr, Davis, CA USA
[6] Harvard Univ, Brigham & Womens Hosp, Cambridge, MA 02138 USA
[7] Tucson Orthoped Inst, Tucson, AZ USA
[8] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2019年 / 27卷
关键词：
D O I：
10.1016/j.joca.2019.02.566
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
728
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    McAlindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Latterman, Christian
    Skrepnik, Nebojsa
    Swearingen, Chris
    DiFrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    Grifman, Mirta
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S12 - S12
  • [2] EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE
    Yazici, Yusuf
    Mcalindon, Timothy
    Gibofsky, Allan
    Lane, Nancy
    Lattermann, Christian
    Skrepnik, Nebojsa
    Swearingen, Christopher
    Difrancesco, Anita
    Tambiah, Jeyanesh
    Hochberg, Marc
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 519 - 519
  • [3] RESULTS FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Lattermann, C.
    Skrepnik, N.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S183 - S184
  • [4] COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTIONS FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
    Yazici, Yusuf
    Tambiah, Jeyanesh
    Swearingen, Christopher
    Kennedy, Sarah
    Strand, Vibeke
    Cole, Brian
    Hochberg, Marc
    Bannuru, Raveendhara
    Mcalindon, Timothy
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 494 - 494
  • [5] COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTION FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT INHIBITOR, FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Tambiah, J.
    Swearingen, C.
    Kennedy, S.
    Strand, V.
    Cole, B.
    Hochberg, M.
    Bannuru, R.
    McAlindon, T.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 : S241 - S242
  • [6] Reducing Heterogeneity in OA Clinical Trials: Data from a Phase 2 Study of SM04690, a Novel, Intra-Articular, Wnt Pathway Inhibitor in Knee Osteoarthritis
    Conaghan, Philip G.
    DiFrancesco, Anita
    Swearingen, Christopher J.
    Kennedy, Sarah
    Simsek, Ismail
    Tambiah, Jeymi
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [7] PROSPECTIVE COMPARISON OF INTRA-ARTICULAR SHAM VS. PLACEBO INJECTIONS: DATA FROM A RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SM04690, A WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Tambiah, J.
    Swearingen, C.
    Kennedy, S.
    Strand, V.
    Cole, B.
    Hochberg, M.
    Bannuru, R.
    McAlindon, T.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S519 - S520
  • [8] Discovery of an Intra-Articular Injection Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Treatment for Knee Osteoarthritis
    Barroga, Charlene
    Hu, Yong
    Deshmukh, Vishal
    Hood, John
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] THE NOVEL, INTRA-ARTICULAR CLK/DYRK1A INHIBITOR LORECIVIVINT (SM04690), A WNT PATHWAY MODULATOR, IMPROVED RESPONDER OUTCOMES IN SUBJECTS WITH KNEE OSTEOARTHRITIS: A POST HOC ANALYSIS FROM A PHASE 2B TRIAL
    Tambiah, J.
    Kennedy, S.
    Swearingen, C.
    Yazici, Y.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S45 - S46
  • [10] Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis
    Strand, Vibeke
    Ghandehari, Heli
    Swearingen, Christopher
    Tambiah, Jeyanesh
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345